BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.

VANCOUVER, BC, Feb. 21, 2024 /PRNewswire/ -- BioVaxys Technology Corp. is pleased to announce has completed the acquisition of the entire portfolio of discovery, preclinical and clinical...

Related Keywords

United Kingdom ,Spain ,Vancouver ,British Columbia ,Canada ,United States ,Frankfurt ,Brandenburg ,Germany ,Canadian ,British ,Kenneth Kovan ,Biovaxys Or Company ,Biovaxys Technology Corp ,Horizon Technology Finance Corporation ,Prnewswire Biovaxys Technology Corp ,Immunovaccine Technologies Inc ,Vaxys Technology ,Asset Purchase Agreement ,Companie Creditors Arrangement Act ,Biovaxys President ,Chief Operating Officer Kenneth Kovan ,Relapsed Refractory Diffuse Largeb Cell Lymphoma ,Frankfurt Bourse ,Markets ,